Last $21.43 USD
Change Today +0.01 / 0.05%
Volume 104.8K
CYNO On Other Exchanges
CYNO is not on other exchanges.
As of 8:10 PM 09/29/14 All times are local (Market data is delayed by at least 15 minutes).

cynosure inc-a (CYNO) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/28/14 - $31.48
52 Week Low
07/28/14 - $18.63
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CYNOSURE INC-A (CYNO)

cynosure inc-a (CYNO) Related Businessweek News

View More BusinessWeek News

cynosure inc-a (CYNO) Details

Cynosure, Inc. develops, manufactures, and markets aesthetic treatment systems primarily to the dermatology, plastic surgery, and general medical markets. Its aesthetic treatment systems incorporate a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:YAG, Er:YAG, Erbium:glass, CO2, and diode lasers, as well as intense pulsed light devices. The company’s aesthetic treatment systems comprise Elite product line for hair removal, treatment of facial, and leg veins and pigmentations; Smartlipo product line for LaserBodySculpting for the removal of unwanted fat; Cellulaze product line for the treatment of cellulite; SmoothShapes XV product line for the temporary reduction in the appearance of cellulite; Affirm/SmartSkin product line for anti-aging applications, including treatments for wrinkles, skin texture, skin discoloration, and skin tightening; Cynergy product line for the treatment of vascular lesions; and Accolade, MedLite C6, and RevLite product lines for the removal of benign pigmented lesions, as well as multi-colored tattoos, as well as PicoSure product line for the treatment of tattoos and benign pigmented lesions. It also distributes the PinPointe FootLaser, a light-based device for the treatment of onychomycosis. The company sells its products through a direct sales force in North America, France, Spain, the United Kingdom, Germany, Korea, China, Japan, Australia, and Mexico, as well as through independent distributors in approximately 120 other countries. Cynosure, Inc. was founded in 1991 and is headquartered in Westford, Massachusetts.

576 Employees
Last Reported Date: 03/17/14
Founded in 1991

cynosure inc-a (CYNO) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $2.2M
President, Chief Operating Officer, Chief Fin...
Total Annual Compensation: $1.4M
Executive Vice President of Worldwide Sales
Total Annual Compensation: $1.0M
Compensation as of Fiscal Year 2013.

cynosure inc-a (CYNO) Key Developments

Cynosure Receives U.S. Food and Drug Administration Approval Expanded Use of Laser Treatment to Wrinkles

Cynosure has received U.S. Food and Drug Administration approval to expand the use of its laser and light-based treatments to cover wrinkles.

Cynosure, Inc. Promotes Timothy W. Baker as President

Timothy W. Baker was recently promoted to president at Cynosure Inc. Baker is also the company's chief financial officer. He has been with Cynosure since 2004.

Cynosure, Inc. Promotes Chris Aronson to Vice President of North American Sales

Cynosure, Inc. announced the promotion of Chris Aronson to Vice President of North American Sales. Aronson, previously Cynosure's Eastern Area Director of Sales, will be responsible for managing the Company's North American direct distribution channel and expanding customer relationships throughout the region. He will report to Doug Delaney, Executive Vice President of Worldwide Sales. Prior to joining Cynosure in 2003, Aronson was regional sales director for Stryker Endoscopy.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYNO:US $21.43 USD +0.01

CYNO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $10.26 USD +0.20
Lutronic Corp 19,700 KRW +650.00
PhotoMedex Inc $6.44 USD -0.38
Syneron Medical Ltd $10.39 USD +0.37
Zeltiq Aesthetics Inc $23.30 USD +0.41
View Industry Companies

Industry Analysis


Industry Average

Valuation CYNO Industry Range
Price/Earnings 42.3x
Price/Sales 1.8x
Price/Book 1.4x
Price/Cash Flow 32.3x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYNOSURE INC-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at